Amicus Therapeutics (NASDAQ:FOLD) PT Raised to $15.00 at Bank of America
Amicus Therapeutics (NASDAQ:FOLD – Free Report) had its price objective upped by Bank of America from $13.00 to $15.00 in a report published on Thursday, Benzinga reports. The brokerage currently has a buy rating on the biopharmaceutical company’s stock. A number of other equities analysts also recently issued reports on the company. Cantor Fitzgerald reiterated […]
20 Oct 07:02 · The Cerbat Gem